RNF31 inhibitors
RNF31 inhibitors

Breaking: Oncology Startup Flindr Raises €20m for Cancer Treatment Breakthrough
BIOT
📢 Flindr Therapeutics BV secures €20m Series A financing! 💰 Funding to advance first-in-class RNF31 inhibitors for cancer treatment. 🩸🔬





